Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACHTREE: CLS-TA for Macular Edema in Uveitis
NCT02595398Phase 3Completed
- Sponsor
- Clearside Biomedical
- Start
- Nov 2015
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of triamcinolone acetonide in macular edema, sponsored by Clearside Biomedical. Started Nov 2015; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT02595398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595398.